Novavax Initiates Late-Stage Trial Of Experimental Coronavirus Vaccine

Novavax Initiates Late-Stage Trial Of Experimental Coronavirus Vaccine

Novavax stock jumped as the biotech company said it will test up to 10,000 volunteers in the U.K. over the next four to six weeks in a late-stage trial of its experimental Covid-19 vaccine.